Playback speed
10 seconds
IMS 2022 Final Analysis of the GRIFFIN Trial: Daratumumab + Lenalidomide, Bortezomib, & Dexamethasone for Transplant-Eligible NDMM
831 views
September 21, 2022
Login to view comments.
Click here to Login